Medicinal Technologies presents Endogen, its 1st ever protocol to be launched.
Product available to the public early 2020
Endogen is a product of Medicinal Technologies, a sector of Tejeda Enterprises Inc. owned by Dr. Sheryene Tejeda. It is the result of a research study conducted by Dr. Tejeda in an effort to provide reversal processes for Endometriosis. Endogen itself is a three part therapeutic matrix that includes addressing the pscho-neuro, bio-physical, and bio-chemical aspects of an individual to attain healing.
Endogen supplements are veggie capsules that contain a combination of all organic ingredients. It’s recommended for the improvement of circulation, and providing restoration to the endocrine system, as well as restoring and maintaining hormonal system balance. The matrix in its entirety was designed to reverse the biological processes that leads to the development of the mono-genetic disorder Endometriosis. Through targeting the mutated gene to deactivate abnormal cell processing, a reversal process is commenced that ultimately leads to cure. The product can also be recommended as an effective treatment for PCOS, fibroids. Although highly recommended, results can not be guaranteed and will differ from one person to another.